The estimated Net Worth of Jeffrey Thomas Elliott is at least 18 百万$ dollars as of 30 April 2024. Mr. Elliott owns over 136 units of Exact Sciences stock worth over 756,295$ and over the last 7 years he sold EXAS stock worth over 12,119,885$. In addition, he makes 5,123,530$ as Chief Financial Officer at Exact Sciences.
Jeffrey has made over 34 trades of the Exact Sciences stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 136 units of EXAS stock worth 8,180$ on 30 April 2024.
The largest trade he's ever made was exercising 90,909 units of Exact Sciences stock on 23 January 2019 worth over 5,829,085$. On average, Jeffrey trades about 9,151 units every 55 days since 2017. As of 30 April 2024 he still owns at least 11,795 units of Exact Sciences stock.
You can see the complete history of Mr. Elliott stock trades at the bottom of the page.
Jeffrey Thomas Elliott serves as Chief Financial Officer of the Company. Mr. Elliott has served as our Chief Financial Officer since November 2016. Prior to his appointment as Chief Financial Officer, Mr. Elliott served as the Company's Vice President, Business Development and Strategy, from June 2016 to November 2016. Prior to joining the Company, from 2007 to 2016, Mr. Elliott was with Robert W. Baird & Co., where from June 2012 to June 2016 he was a senior research analyst who covered diagnostics and life science tools companies. Earlier in his career, Mr. Elliott worked in a supply chain role for Walgreens and as a consultant at Cap Gemini Ernst & Young. Mr. Elliott earned a bachelor's degree in business administration from the University of Illinois at Urbana-Champaign and an MBA from the University of Chicago Booth School of Business. Mr. Elliott is a CFA charterholder.
As the Chief Financial Officer of Exact Sciences, the total compensation of Jeffrey Elliott at Exact Sciences is 5,123,530$. There are 2 executives at Exact Sciences getting paid more, with Kevin Conroy having the highest compensation of 18,716,500$.
Jeffrey Elliott is 42, he's been the Chief Financial Officer of Exact Sciences since 2016. There are 25 older and no younger executives at Exact Sciences. The oldest executive at Exact Sciences Corp. is James Doyle, 74, who is the Independent Director.
Jeffrey's mailing address filed with the SEC is C/O QUANTERIX CORPORATION, 900 MIDDLESEX TURNPIKE, BILLERICA, MA, 01821.
Over the last 21 years, insiders at Exact Sciences have traded over 118,141,352$ worth of Exact Sciences stock and bought 191,930 units worth 1,451,887$ . The most active insiders traders include Kevin T Conroy、Edwin M Jr Kania、Maneesh Arora. On average, Exact Sciences executives and independent directors trade stock every 12 days with the average trade being worth of 1,667,056$. The most recent stock trade was executed by Brian Baranick on 5 August 2024, trading 2,712 units of EXAS stock currently worth 173,893$.
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Exact Sciences executives and other stock owners filed with the SEC include: